Home › Funds › Cormorant Asset Management, LP › CABA
Cormorant Asset Management, LP position in CABA
CABALETTA BIO INC · Health Care
Cormorant Asset Management, LP reported holding 5,000,000 shares of CABA (CABALETTA BIO INC) in its Q2 2026 13F filing — a position valued at US$15.6M, representing 0.80% of its reported portfolio and ranking #30 among its reported holdings. Cormorant Asset Management, LP has disclosed CABA holdings in 7 of the last 12 reported quarters, going back to Q3 2023.
Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR
How Cormorant Asset Management, LP's CABA position evolved
Cormorant Asset Management, LP first disclosed a stake in CABA in Q3 2023 at 2,879,424 shares (US$43.8M). Across 7 filings, Cormorant Asset Management, LP increased the stake 1 time(s), trimmed it 2 time(s) and left it unchanged 1 time(s). The most recent filing (Q2 2026) shows 5,000,000 shares valued at US$15.6M — a reduction of -500,000 shares quarter over quarter.. Notable position changes include a 25% increase in Q1 2026 (shares rose 16% over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2023 | 2.88M | $43.82M | New |
| Q1 2024 | 1.10M | $18.77M | New |
| Q2 2025 | 5.00M | $7.60M | New |
| Q3 2025 | 5.00M | $11.70M | Hold |
| Q4 2025 | 4.40M | $9.64M | Reduce |
| Q1 2026 | 5.50M | $14.79M | Add |
| Q2 2026 | 5.00M | $15.55M | Reduce |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About CABA and 13F data
CABA (CABALETTA BIO INC) is a Health Care company. 37 other funds we track also report a position in CABA — the largest reported positions include Bain Capital Life Sciences Investors, LLC (US$53.6M), Opaleye Management Inc. (US$12.0M), SUPERSTRING CAPITAL MANAGEMENT LP (US$3.5M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding CABA
- Bain Capital Life Sciences Investors, LLC 17.24M sh · $53.62M · Q2 2026
- Opaleye Management Inc. 3.86M sh · $12.02M · Q2 2026
- SUPERSTRING CAPITAL MANAGEMENT LP 1.28M sh · $3.48M · Q2 2026
- Stonepine Capital Management, LLC 917.10K sh · $2.85M · Q2 2026
- Blue Owl Capital Holdings LP 714.71K sh · $2.22M · Q2 2026
More on Cormorant Asset Management, LP
FAQ
How long has Cormorant Asset Management, LP held CABA?
Cormorant Asset Management, LP has disclosed CABA holdings in 7 of the last 12 reported quarters, going back to Q3 2023.
What is Cormorant Asset Management, LP's current position in CABA?
As of Q2 2026, Cormorant Asset Management, LP holds 5.00M shares of CABA (CABALETTA BIO INC), valued at $15.55M, representing 0.80% of its reported portfolio and ranking #30.
Has Cormorant Asset Management, LP been buying or selling CABA?
In the latest 13F filing (Q2 2026), Cormorant Asset Management, LP reduced its position in CABA.
Which other funds hold CABA?
Other major institutional holders of CABA include Bain Capital Life Sciences Investors, LLC, Opaleye Management Inc., SUPERSTRING CAPITAL MANAGEMENT LP, among 37 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.